Back to search

Article

Proving equivalence of originator and an authorized generic drug following EMA draft guideline on quality and equivalence of topical products

2024-06-06

Abstract excerpt

<h4>Aim: </h4> Today, the approval for a generic topical product includes the presentation of therapeutic equivalence to the originator based on clinical trials. To facilitate this procedure, in 2018 the European Medicines Agency (EMA) published a draft guideline on quality and equivalence of topical products, which includes request parameters regarding the quality of the newly developed generic product and test p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7bc97c0-16fb-5afd-9876-5f77a50f05a7
DOI
10.22541/au.171600574.43353285/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Proving equivalence of originator and an authorized generic drug following EMA draft guideline on quality and equivalence of topical productsDOI 10.22541/au.171600574.43353285/v2
Select a neighboring publication to make it the new centre.